Stocktoria
PROCYON CORP PCYN
PROCYON CORP (PCYN) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2024 revenue was $5.0M at a -6.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.1 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
How it ranks in Manufacturing · percentile among 2036 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.498 |
| Retained earnings / assets | -0.727 |
| EBIT / assets | -0.072 |
| Equity / liabilities | 2.494 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| PCYN | PROCYON CORP | 3/9 | 3.03 | — | — |
| ENSC | Ensysce Biosciences, Inc. | — | — | — | — |
| ABEO | ABEONA THERAPEUTICS INC. | 4/9 | -5.75 | 4.5 | — |
| CPHI | CHINA PHARMA HOLDINGS, INC. | 4/9 | -3.85 | — | — |
| ATAI | AtaiBeckley Inc. | 4/9 | — | — | — |
| CRVO | CervoMed Inc. | 1/9 | -12.9 | — | — |
| KRRO | Korro Bio, Inc. | 2/9 | -13.3 | — | — |
About PROCYON CORP
Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calcium alginate dressing, foam dressing, amerx gauze dressing, hyrdocolloid dressing, as well as wound care kits, including calcium alginate, collagen matrix, collagen powder, foam, hydrogel, and rolled gauze wound care kits under the AMERX brand. The company also offers AMERIGEL hand sanitizer; EXTREMIT-EASE compression garment products; Advantagen, a surgical collagen powder that promotes wound closure and reduces the potential for surgical site infection; calcium alginate, foam, and gauze dressings; retention tapes; and helix collagen gel. It sells its products to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, physicians, and other health care practitioners; and retail customers through distributors, and direct and internet sales, as well as through independent and retail chain drug stores. Procyon Corporation was incorporated in 1987 and is based in Oldsmar, Florida.
FAQ
Is PCYN financially healthy?
PROCYON CORP's Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does PCYN pay a dividend?
No, PROCYON CORP does not currently pay a dividend.
How profitable is PCYN?
In FY2024, PROCYON CORP had a net margin of -6.8% and a return on equity of -14.9%.
Is PCYN overvalued or undervalued?
PROCYON CORP trades at about 3.4× trailing earnings — below its 10-year norm (10-year range 5.2×–21.0×, median 20.0×). Stocktoria reports the data, not buy/sell advice.
Is PCYN a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on PROCYON CORP: a Piotroski F-score of 3/9, an Altman Z″ in the safe zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2024-06-30. Facts plus Stocktoria's own computed scores — not investment advice.